APO RESEARCH · REPORT
Dronabinol
Dronabinol is a form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). THC demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, which results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. Due to its evidence as an appetite stimulant and an anti-nauseant, Dronabinol is approved for use in anorexia associated with weight loss in patients with AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Product & engineering
Understand the product.
Dronabinol is a form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). THC demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, which results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. Due to its evidence as an appetite stimulant and an anti-nauseant, Dronabinol is approved for use in anorexia associated with weight loss in patients with AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Selected research
Industry Growth & Trends
Global Dronabinol Industry Growth and Trends Forecast to 2032
Market perspective
Dronabinol is a form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). THC demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, which results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. Due to its evidence as an appetite stimulant and an anti-nauseant, Dronabinol is approved for use in anorexia associated with weight loss in patients with AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Global key players of Dronabinol include Canopy Growth, Noramco, THC Pharm, Echo Pharmaceuticals, BOL Pharma and Aphios Corporation, etc. Top five players occupy for a share about 44%. North America is the largest market, with a share about 58%, followed by Europe and Asia-Pacific. In terms of product, Synthetic Dronabinol is the largest segment, with a share over 86%. In terms of application, Capsule is the largest market, with a share over 66%.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Dronabinol market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Dronabinol market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dronabinol market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dronabinol.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Dronabinol market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Dronabinol Market by Company
Canopy Growth
Noramco
KinetoChem
Entourage Phytolab
THC Pharm
Echo Pharmaceuticals
BOL Pharma
Aphios Corporation
Benuvia Manufacturing
Dronabinol Segment by Type
Synthetic Dronabinol
Natural Dronabinol
Dronabinol Segment by Application
Capsule
Oral Liquid
Dronabinol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dronabinol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dronabinol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dronabinol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dronabinol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Dronabinol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Synthetic Dronabinol
- Natural Dronabinol
Applications
- Capsule
- Oral Liquid
Companies covered
- Canopy Growth
- Noramco
- KinetoChem
- Entourage Phytolab
- THC Pharm
- Echo Pharmaceuticals
- BOL Pharma
- Aphios Corporation
- Benuvia Manufacturing
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Dronabinol Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Dronabinol Sales Estimates and Forecasts (2021-2032)
- 1.3 Dronabinol Market by Type
- 1.3.1 Synthetic Dronabinol
- 1.3.2 Natural Dronabinol
- 1.4 Global Dronabinol Market Size by Type
- 1.4.1 Global Dronabinol Market Size Overview by Type (2021-2032)
- 1.4.2 Global Dronabinol Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Dronabinol Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Dronabinol Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Dronabinol Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Dronabinol Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Dronabinol Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Dronabinol Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Dronabinol Industry Trends
- 2.2 Dronabinol Industry Drivers
- 2.3 Dronabinol Industry Opportunities and Challenges
- 2.4 Dronabinol Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Dronabinol Revenue (2021-2026)
- 3.2 Global Top Players by Dronabinol Sales (2021-2026)
- 3.3 Global Top Players by Dronabinol Price (2021-2026)
- 3.4 Global Dronabinol Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Dronabinol Major Company Production Sites & Headquarters
- 3.6 Global Dronabinol Company, Product Type & Application
- 3.7 Global Dronabinol Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Dronabinol Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Dronabinol Players Market Share by Revenue in 2025
- 3.8.3 2025 Dronabinol Tier 1, Tier 2, and Tier 3
4 Dronabinol Regional Status and Outlook
- 4.1 Global Dronabinol Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Dronabinol Historic Market Size by Region
- 4.2.1 Global Dronabinol Sales in Volume by Region (2021-2026)
- 4.2.2 Global Dronabinol Sales in Value by Region (2021-2026)
- 4.2.3 Global Dronabinol Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Dronabinol Forecasted Market Size by Region
- 4.3.1 Global Dronabinol Sales in Volume by Region (2027-2032)
- 4.3.2 Global Dronabinol Sales in Value by Region (2027-2032)
- 4.3.3 Global Dronabinol Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dronabinol by Application
- 5.1 Dronabinol Market by Application
- 5.1.1 Capsule
- 5.1.2 Oral Liquid
- 5.2 Global Dronabinol Market Size by Application
- 5.2.1 Global Dronabinol Market Size Overview by Application (2021-2032)
- 5.2.2 Global Dronabinol Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Dronabinol Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Dronabinol Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Dronabinol Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Dronabinol Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Dronabinol Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Dronabinol Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Canopy Growth
- 6.1.1 Canopy Growth Company Information
- 6.1.2 Canopy Growth Business Overview
- 6.1.3 Canopy Growth Dronabinol Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Canopy Growth Dronabinol Product Portfolio
- 6.1.5 Canopy Growth Recent Developments
- 6.2 Noramco
- 6.2.1 Noramco Company Information
- 6.2.2 Noramco Business Overview
- 6.2.3 Noramco Dronabinol Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Noramco Dronabinol Product Portfolio
- 6.2.5 Noramco Recent Developments
- 6.3 KinetoChem
- 6.3.1 KinetoChem Company Information
- 6.3.2 KinetoChem Business Overview
- 6.3.3 KinetoChem Dronabinol Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 KinetoChem Dronabinol Product Portfolio
- 6.3.5 KinetoChem Recent Developments
- 6.4 Entourage Phytolab
- 6.4.1 Entourage Phytolab Company Information
- 6.4.2 Entourage Phytolab Business Overview
- 6.4.3 Entourage Phytolab Dronabinol Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Entourage Phytolab Dronabinol Product Portfolio
- 6.4.5 Entourage Phytolab Recent Developments
- 6.5 THC Pharm
- 6.5.1 THC Pharm Company Information
- 6.5.2 THC Pharm Business Overview
- 6.5.3 THC Pharm Dronabinol Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 THC Pharm Dronabinol Product Portfolio
- 6.5.5 THC Pharm Recent Developments
- 6.6 Echo Pharmaceuticals
- 6.6.1 Echo Pharmaceuticals Company Information
- 6.6.2 Echo Pharmaceuticals Business Overview
- 6.6.3 Echo Pharmaceuticals Dronabinol Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Echo Pharmaceuticals Dronabinol Product Portfolio
- 6.6.5 Echo Pharmaceuticals Recent Developments
- 6.7 BOL Pharma
- 6.7.1 BOL Pharma Company Information
- 6.7.2 BOL Pharma Business Overview
- 6.7.3 BOL Pharma Dronabinol Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 BOL Pharma Dronabinol Product Portfolio
- 6.7.5 BOL Pharma Recent Developments
- 6.8 Aphios Corporation
- 6.8.1 Aphios Corporation Company Information
- 6.8.2 Aphios Corporation Business Overview
- 6.8.3 Aphios Corporation Dronabinol Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Aphios Corporation Dronabinol Product Portfolio
- 6.8.5 Aphios Corporation Recent Developments
- 6.9 Benuvia Manufacturing
- 6.9.1 Benuvia Manufacturing Company Information
- 6.9.2 Benuvia Manufacturing Business Overview
- 6.9.3 Benuvia Manufacturing Dronabinol Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Benuvia Manufacturing Dronabinol Product Portfolio
- 6.9.5 Benuvia Manufacturing Recent Developments
7 North America by Country
- 7.1 North America Dronabinol Sales by Country
- 7.1.1 North America Dronabinol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Dronabinol Sales by Country (2021-2026)
- 7.1.3 North America Dronabinol Sales Forecast by Country (2027-2032)
- 7.2 North America Dronabinol Market Size by Country
- 7.2.1 North America Dronabinol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Dronabinol Market Size by Country (2021-2026)
- 7.2.3 North America Dronabinol Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Dronabinol Sales by Country
- 8.1.1 Europe Dronabinol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Dronabinol Sales by Country (2021-2026)
- 8.1.3 Europe Dronabinol Sales Forecast by Country (2027-2032)
- 8.2 Europe Dronabinol Market Size by Country
- 8.2.1 Europe Dronabinol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Dronabinol Market Size by Country (2021-2026)
- 8.2.3 Europe Dronabinol Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Dronabinol Sales by Country
- 9.1.1 Asia-Pacific Dronabinol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Dronabinol Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Dronabinol Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Dronabinol Market Size by Country
- 9.2.1 Asia-Pacific Dronabinol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Dronabinol Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Dronabinol Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Dronabinol Sales by Country
- 10.1.1 South America Dronabinol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Dronabinol Sales by Country (2021-2026)
- 10.1.3 South America Dronabinol Sales Forecast by Country (2027-2032)
- 10.2 South America Dronabinol Market Size by Country
- 10.2.1 South America Dronabinol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Dronabinol Market Size by Country (2021-2026)
- 10.2.3 South America Dronabinol Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Dronabinol Sales by Country
- 11.1.1 Middle East and Africa Dronabinol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Dronabinol Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Dronabinol Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Dronabinol Market Size by Country
- 11.2.1 Middle East and Africa Dronabinol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Dronabinol Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Dronabinol Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Dronabinol Value Chain Analysis
- 12.1.1 Dronabinol Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Dronabinol Production Mode & Process
- 12.2 Dronabinol Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Dronabinol Distributors
- 12.2.3 Dronabinol Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst